Role of Radiologic Modalities in the Management of Non-alcoholic Steatohepatitis

Clinics in Liver Disease

Volumn 11, Issue 1, 2007, Pages 37-54

  Charatcharoenwitthaya, Phunchai ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; PIOGLITAZONE; ROSIGLITAZONE;

AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DOPPLER ECHOGRAPHY; DRUG SENSITIZATION; FATTY LIVER; HEPATITIS; HUMAN; INSULIN SENSITIVITY; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER NECROSIS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS; REVIEW; SIDE EFFECT; STEATOSIS; WEIGHT GAIN;

FATTY LIVER; HEPATITIS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 34249682613     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2007.02.014     Document Type: Review

References (67)

1. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 (2003) 960-967
2. Angulo P., and Lindor K.D. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17 Suppl (2002) S186-S190
3. Stephen C.H., Tri H.L., and Stacey M.A. Non-alcoholic steatohepatitis. Textbook. Sciff's disease of the liver. 9th edition (2002), Lippincott William & Wilkins, Philadephia 1261-1289
4. Brunt E.M., Janney C.G., Di Bisceglie A.M., et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
5. Longo R., Pollesello P., Ricci C., et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5 (1995) 281-285
6. Promrat K., Lutchman G., Uwaifo G.I., et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39 (2004) 188-196
7. Fishbein M.H., Mogren C., Gleason T., et al. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 42 (2006) 83-88
8. Oliva M.R., Mortele K.J., Segatto E., et al. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 30 (2006) 37-43
9. Foster K.J., Dewbury K.C., Griffith A.H., et al. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 53 (1980) 440-442
10. Debongnie J.C., Pauls C., Fievez M., et al. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 22 (1981) 130-135
11. Taylor K.J., Gorelick F.S., Rosenfield A.T., et al. Ultrasonography of alcoholic liver disease with histological correlation. Radiology 141 (1981) 157-161
12. Meek D.R., Mills P.R., Gray H.W., et al. A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease. Br J Radiol 57 (1984) 23-27
13. Saverymuttu S.H., Joseph A.E., and Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 292 (1986) 13-15
14. Joseph A.E., Saverymuttu S.H., al-Sam S., et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43 (1991) 26-31
15. Mathiesen U.L., Franzen L.E., Aselius H., et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 34 (2002) 516-522
16. Yeh W.C., Jeng Y.M., Li C.H., et al. Liver steatosis classification using high-frequency ultrasound. Ultrasound Med Biol 31 (2005) 599-605
17. Von Herbay A., Frieling T., and Haussinger D. Association between duplex Doppler sonographic flow pattern in right hepatic vein and various liver diseases. J Clin Ultrasound 29 (2001) 25-30
18. Dietrich C.F., Lee J.H., Gottschalk R., et al. Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. AJR Am J Roentgenol 171 (1998) 437-443
19. Oguzkurt L., Yildirim T., Torun D., et al. Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 54 (2005) 253-257
20. Kawata R., Sakata K., Kunieda T., et al. Quantitative evaluation of fatty liver by computed tomography in rabbits. Am J Roentgenol 142 (1984) 741-746
21. Mendler M.H., Bouillet P., Le Sidaner A., et al. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 28 (1998) 785-794
22. Tsushima Y., Aoki J., and Endo K. The effect of fatty infiltration on the liver tissue enhancement during portal phase computed tomography. Acad Radiol 10 (2003) 1008-1012
23. Lautt W.W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 249 (1985) G549-G556
24. Todo S., Demetris A.J., Makowka L., et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47 (1989) 903-905
25. Tsushima Y., and Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci 45 (2000) 196-200
26. Castro M.A., Ouzounian J.G., Colletti P.M., et al. Radiologic studies in acute fatty liver of pregnancy. A review of the literature and 19 new cases. J Reprod Med 41 (1996) 839-843
27. Stark D.D., Moss A.A., and Goldberg H.I. Nuclear magnetic resonance of the liver, spleen, and pancreas. Cardiovasc Intervent Radiol 8 (1986) 329-341
28. Rofsky N.M., Weinreb J.C., Ambrosino M.M., et al. Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. J Comput Assist Tomogr 20 (1996) 230-235
29. Venkataraman S., Braga L., and Semelka R.C. Imaging the fatty liver. Magn Reson Imaging Clin N Am 10 (2002) 93-103
30. Sallie R.W., Reed W.D., and Shilkin K.B. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 32 (1991) 207-210
31. Valls C., Iannacconne R., Alba E., et al. Fat in the liver: diagnosis and characterization. Eur Radiol 14 (2006) 1-17
32. Qayyum A., Goh J.S., Kakar S., et al. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 237 (2005) 507-511
33. Ros P.R., and Mortele K.J. Diffuse liver disease. Clin Liver Dis 6 (2002) 181-201
34. Kawamori Y., Matsui O., Takahashi S., et al. Focal hepatic fatty infiltration in the posterior edge of the medial segment associated with aberrant gastric venous drainage: CT, US, and MR findings. J Comput Assist Tomogr 20 (1996) 356-359
35. Matsui O., Kadoya M., Takahashi S., et al. Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage. Am J Roentgenol 164 (1995) 1137-1140
36. Arai K., Matsui O., Takashima T., et al. Focal spared areas in fatty liver caused by regional decreased portal flow. Am J Roentgenol 151 (1988) 300-302
37. Sohn J., Siegelman E., and Osiason A. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. Am J Roentgenol 176 (2000) 471-474
38. Siegelman E.S., and Rosen M.A. Imaging of hepatic steatosis. Semin Liver Dis 21 (2001) 71-80
39. Hamer O.W., Aguirre D.A., Casola G., et al. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology 237 (2005) 159-169
40. Kemper J., Jung G., Poll L.W., et al. CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging 27 (2002) 708-710
41. Chan D.F., Li A.M., Chu W.C., et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 28 (2004) 1257-1263
42. Tominaga K., Kurata J.H., Chen Y.K., et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 40 (1995) 2002-2009
43. Fusamoto H., Suzuki K., Hayashi N., et al. Obesity and liver disease: evaluation of fatty infiltration of the liver using ultrasonic attenuation. J Nutr Sci Vitaminol 37 Suppl (1991) S71-S77
44. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 745-750
45. Ducommun J.C., Goldberg H.I., Korobkin M., et al. The relation of liver fat to computed tomography numbers: a preliminary experimental study in rabbits. Radiology 130 (1979) 511-513
46. Piekarski J., Goldberg H.I., Royal S.A., et al. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137 (1980) 727-729
47. Limanond P., Raman S.S., Lassman C., et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230 (2004) 276-280
48. Ricci C., Longo R., Gioulis E., et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 27 (1997) 108-113
49. Jacobs J.E., Birnbaum B.A., Shapiro M.A., et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. Am J Roentgenol 171 (1998) 659-664
50. Fishbein M.H., Gardner K.G., Potter C.J., et al. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 15 (1997) 287-293
51. Fishbein M.H., and Stevens W.R. Rapid MRI using a modified Dixon technique: a non-invasive and effective method for detection and monitoring of fatty metamorphosis of the liver. Pediatr Radiol 31 (2001) 806-809
52. Fishbein M., Castro F., Cheruku S., et al. Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 39 (2005) 619-625
53. Szczepaniak L.S., Nurenberg P., Leonard D., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005) E462-E468
54. Szczepaniak L.S., Babcock E.E., Schick F., et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 276 (1999) E977-E989
55. Thomsen C., Becker U., Winkler K., et al. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12 (1994) 487-495
56. Longo R., Ricci C., Masutti F., et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28 (1993) 297-302
57. Simha V., Szczepaniak L.S., Wagner A.J., et al. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 26 (2003) 30-35
58. Tiikkainen M., Bergholm R., Vehkavaara S., et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52 (2003) 701-707
59. Brunt E.M., Neuschwander-Tetri B.A., Oliver D., et al. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 35 (2004) 1070-1082
60. Ataseven H., Yildirim M.H., Yalniz M., et al. The value of ultrasonography and computerized tomography in estimating the histopathological severity of nonalcoholic steatohepatitis. Acta Gastroenterol Belg 68 (2005) 221-225
61. Younossi Z., Gramlich T., Liu Y., et al. Non-alcoholic fatty liver: assessment of variability in the pathologic interpretations. Modern Pathology 11 6 (1998) 560-565
62. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
63. Moriyasu F., Iijima H., Tsuchiya K., et al. Diagnosis of NASH using delayed parenchymal imaging of contrast ultrasound. Hepatol Res 33 (2005) 97-99
64. Foucher J., Chanteloup E., Vergniol J., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 (2006) 403-408
65. Ziol M., Handra-Luca A., Kettaneh A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
66. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
67. Mazess R.B., Barden H.S., Bisek J.P., et al. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51 (1990) 1106-1112